CBDBY Statistics
Total Valuation
CBDBY has a market cap or net worth of $218.06 million. The enterprise value is $1.42 billion.
| Market Cap | 218.06M |
| Enterprise Value | 1.42B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.49% |
| Float | 209.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.44 |
| PS Ratio | 0.07 |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/FCF Ratio | 0.40 |
| PEG Ratio | 3.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.65, with an EV/FCF ratio of 2.60.
| EV / Earnings | n/a |
| EV / Sales | 0.43 |
| EV / EBITDA | 3.65 |
| EV / EBIT | 59.63 |
| EV / FCF | 2.60 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.61 |
| Quick Ratio | 0.29 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 4.94 |
| Debt / FCF | 3.52 |
| Interest Coverage | 0.17 |
Financial Efficiency
Return on equity (ROE) is -1.40% and return on invested capital (ROIC) is -1.67%.
| Return on Equity (ROE) | -1.40% |
| Return on Assets (ROA) | -0.40% |
| Return on Capital (ROIC) | -1.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.27 |
Taxes
| Income Tax | -87.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.19% in the last 52 weeks. The beta is 1.17, so CBDBY's price volatility has been higher than the market average.
| Beta (1Y) | 1.17 |
| 52-Week Price Change | -84.19% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 46.08 |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | 1.16M |
| Short Previous Month | 940,113 |
| Short % of Shares Out | 1.25% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.72 |
Income Statement
In the last 12 months, CBDBY had revenue of $3.27 billion and -$32.51 million in losses. Loss per share was -$0.12.
| Revenue | 3.27B |
| Gross Profit | 827.96M |
| Operating Income | -69.29M |
| Pretax Income | -120.48M |
| Net Income | -32.51M |
| EBITDA | 389.92M |
| EBIT | 23.86M |
| Loss Per Share | -$0.12 |
Balance Sheet
The company has $721.92 million in cash and $1.93 billion in debt, giving a net cash position of -$1.20 billion.
| Cash & Cash Equivalents | 721.92M |
| Total Debt | 1.93B |
| Net Cash | -1.20B |
| Net Cash Per Share | n/a |
| Equity / Book Value | 2.21B |
| Book Value Per Share | n/a |
| Working Capital | 2.08B |
Cash Flow
In the last 12 months, operating cash flow was -$41.57 million and capital expenditures $589.31 million, giving a free cash flow of $547.74 million.
| Operating Cash Flow | -41.57M |
| Capital Expenditures | 589.31M |
| Free Cash Flow | 547.74M |
| FCF Per Share | $2.03 |
Margins
Gross margin is 25.29%, with operating and profit margins of -2.12% and -0.99%.
| Gross Margin | 25.29% |
| Operating Margin | -2.12% |
| Pretax Margin | -3.68% |
| Profit Margin | -0.99% |
| EBITDA Margin | 11.91% |
| EBIT Margin | 0.73% |
| FCF Margin | 16.73% |
Dividends & Yields
CBDBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | -14.91% |
| FCF Yield | 251.19% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 18, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Oct 18, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CBDBY has an Altman Z-Score of 0.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 2 |